References
- Alexander, C., Swanson, K. S., Fahey, G. C., Garleb, K. A., (2017). Perspective: Physiologic importance of short-chain fatty acids from nondigestible carbohydrate fermentation. Adv, Nutr., 10 (4), 576–589.
- Bach Knudsen, K. E. (2015). Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health. Adv, Nutr., 6 (2), 206–213.10.3945/an.114.007450435217925770259
- Hoda, M., Wright, M. L., Anil Kumar, N. V., Qawasmeh, Abdel, Hassan Sherif T. S., Mocan, A., Nabavi, S. M., Rastrelli, L., Atanasov, A. G., Haddad, P. S. (2017). Significance of microbiota in obesity and metabolic diseases and the modulatory potential by medicinal plant and food ingredients. Front Pharmacol., 8, 387.
- Holscher, H. D. (2017). Dietary fibre and prebiotics and the gastrointestinal microbiota. Gut Microbes, 48 (2), 172–184.10.1080/19490976.2017.1290756539082128165863
- Ingerslev, A. K., Theil, P. K., Hedemann, M. S., L¿rke, H. N., Bach Knudsen, K. E. (2014). Resistant starch and arabinoxylan augment SCFA absorption, but affect postprandial glucose and insulin responses differently. Brit. J. Nutr., 111 (9), 1564–1576.10.1017/S000711451300406624507768
- Jefferson, A., Adolphus, K., (2019). The effects of intact cereal grain fibres, including wheat bran on the gut microbiota composition of healthy adults: A systematic review. Front Nutr., 6 3310.3389/fnut.2019.00033644947330984765
- McNabney, S. M., Henagan, T. M., (2017). Short chain fatty acids in the colon and peripheral tissues: A focus on butyrate, colon cancer, obesity and insulin resistance. Pharmacol. Res., 120, 34–42.10.3390/nu9121348574879829231905
- Meija, L., Soderholm, P., Samaletdin, A., Ignace, G., Siksna, I., Joffe, R., Lejnieks, A., Lietuvietis, V., Krams, I., Adlercreutz, H. (2013). Dietary in-take and major sources of plant lignans in Latvian men and women. Int. J. Food Sci. Nutr., 64 (5), 535–543.10.3109/09637486.2013.76583523373826
- Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., Gazzaruso, C. (2018). Microbiota and metabolic diseases. Endocrine,61, 357–371.10.1007/s12020-018-1605-529721802
- Pucci, G., Alcidi, R., Tap, L., Battista, F., Mattace-Raso, F, Schillaci, G. (2017). Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol. Res.,120, 34–42.10.1016/j.phrs.2017.03.00828300617
- Sherling, D. H., Perumareddi, P., Hennekens, C. H. (2017). Metabolic syndrome: Clinical and policy implications of the new silent killer. J. Cardiovasc. Pharmacol. Ther.,22 (4), 365–367.10.1177/107424841668618728587579
- Vetrani, C., Costabile, G., Luongo, D., Naviglio, D., Rivellese, A. A., Riccardi, G., Giacco, R., (2016). Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome. Nutrition, 32 (2), 217–221.10.1016/j.nut.2015.08.00626706023